 CAMBRIDGE, Mass.--BUSINESS WIRE--InVivo Therapeutics Holdings Corp. Nasdaq: NVIV today announced the recent publication of a peer-reviewed manuscript in the Journal of Neurosurgery: Spine describing the previously presented complete six-month primary endpoint results from the companys single-arm INSPIRE 1.0 study InVivo Study of Probable Benefit of the Neuro-Spinal ScaffoldTM for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury, titled A study of 